Key | % Net Assets |
---|---|
Lincoln National | 2.7% |
Merck & Co | 2.6% |
Nucor | 2.6% |
JP Morgan | 2.6% |
Other | 89.5% |
Name | % Net Assets |
---|---|
Lincoln National | 2.7% |
Merck & Co | 2.6% |
Nucor | 2.6% |
JP Morgan | 2.6% |
Hartford Financial | 2.5% |
Morgan Stanley | 2.5% |
Wells Fargo | 2.5% |
Pfizer | 2.5% |
Apache | 2.5% |
Cigna | 2.5% |
No asset data available.
Date | 21-Nov-2024 |
---|---|
NAV | 246.17p |
Currency | GBP |
Change | 0.14p |
% | 0.06% |
YTD change | 36.14p |
YTD % | 17.21% |
Fund Inception | 01/07/2005 |
---|---|
Fund Manager | Richard Brody |
TER | 1.69 (28-Feb-2014) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £10 |
Savings | £10 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.02 |
You are here: research